TrialJournal of clinical pharmacology2022

Fluoride Pharmacokinetics in Urine and Plasma Following Multiple Doses of MK-8507, an Investigational, Oral, Once-Weekly Nonnucleoside Reverse Transcriptase Inhibitor.

Gillian Gillespie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.